Pharmacy benefit managers took in nearly $1.6 billion in extra revenue on two cancer drugs in less than three years, a new FTC report finds.
Axios’ Post
More Relevant Posts
-
Following my last post (see link), FDA approved Pfizer’s #Elrexfio, (#elranatamab), for patients with multiple myeloma who've tried at least four prior lines of therapy. Elrexfio will go toe to toe with Johnson & Johnson’s #Tecvayli. Both drugs are bispecific antibodies that engage T cells to target #BCMA-expressing cancer cells, and both are delivered subdermally. So far, the two therapies’ efficacy data are largely similar, while Elrexfio appears to boast a convenience edge—for now. Previous Tecvayli post: https://lnkd.in/eYcKuG4f https://lnkd.in/e6mDCMQN #artificialintelligence #dataanalysis #datascientist #innovation #datastrategy #multiplemyeloma #digitalhealth #digitalhealthplatform #talvey #tcells
With FDA approval for Elrexfio, Pfizer brings multiple myeloma battle to Johnson & Johnson
fiercepharma.com
To view or add a comment, sign in
-
In a recent AJMC - The American Journal of Managed Care article, Melody Chang AON Vice President Pharmacy Operations, discusses the challenges dealing with the ongoing cancer drug shortages and what AON is doing to address the issue. Read the article > https://hubs.li/Q02091d50
Contributor: Grappling With Ongoing Cancer Drug Shortages
ajmc.com
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Bristol Myers wins accelerated approval for another blood cancer for blockbuster Breyanzi >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #biotech #pharma #pharmaceutical #healthcare
Bristol Myers' CAR-T therapy Breyanzi adds follicular lymphoma to list of approvals
https://endpts.com
To view or add a comment, sign in
-
Thoughts on this? >> Bristol Myers wins accelerated approval for another blood cancer for blockbuster Breyanzi >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #pharmaceutical #healthcare #biotech
Bristol Myers' CAR-T therapy Breyanzi adds follicular lymphoma to list of approvals
https://endpts.com
To view or add a comment, sign in
-
The FTC published a report last week... It highlights the power PBMs have on the accessibility and affordability of prescription drugs. 💡 The 6 largest PBMs manage 95% of all prescriptions in the USA, which has allowed them to hike the cost of drugs, including overcharging patients for cancer drugs. The report details how smaller pharmacies are forced to contract with PBMs, and often receive unfair contractual terms that impact their ability to run their business. Please share your thoughts in the comments! 👉 https://lnkd.in/e9a-MHMF #CHM #Carneros #PBM #Cancer
FTC Releases Interim Staff Report on Prescription Drug Middlemen
ftc.gov
To view or add a comment, sign in
-
HBA Director of Programming - Phoenix 🧬 Pharma/Biotech Consulting 👩🏻🔬 Oncology, IDN & Value-Based Care Strategist. 🔬 Rescue Dog & Coffee Enthusiast. 🐕 Market Access & Go-To-Market Planning/Execution.
The cancer drug shortage continues to worsen in the US with no end in sight. While many people love to shout that Rx prices are too high, the median CMS allowable reimbursement for the most of these commonly used life-saving vials of drugs facing these shortages is $14.40. "there are several other so-called “fixes” that some in Congress are pushing that will do nothing, and in fact may even worsen the problem. For example, giving the FDA more power to oversee manufacturers won’t do anything to fix shortages when no one is producing the product." https://lnkd.in/gkvZiU_M #pharma #oncology #infusion #drugshortages #drugpricing #accesstocare
The harsh economic reality of cancer drug shortages
https://thehill.com
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> FDA says chemotherapy cisplatin is no longer in short supply >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #healthcare #biotech #pharma
FDA says cancer drug cisplatin is no longer in shortage
https://endpts.com
To view or add a comment, sign in
-
BioPharma & HealthTech Competitive Strategy & Insights | Digital & AI Solutions | Gene & Cell Therapy | Vaccines
Thoughts on this? >> Sanofi settles about 4,000 cases in state court over Zantac cancer claims >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #pharmaceutical #pharma #healthcare #biotech
Sanofi ends almost all state personal injury lawsuits over Zantac with undisclosed settlement
https://endpts.com
To view or add a comment, sign in
-
Thoughts on this? >> Sanofi settles about 4,000 cases in state court over Zantac cancer claims >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #productmarketing #healthcare #pharma #biotech
Sanofi ends almost all state personal injury lawsuits over Zantac with undisclosed settlement
https://endpts.com
To view or add a comment, sign in